Pear Therapeutics
Latest round
- Series D
Last raised
- Dec 2020
Total raised
- $203M
Investors
- 16
About Pear Therapeutics
Founded in 2013 and based in Massachusetts, US, Pear Therapeutics, Inc. provides an end-to-end platform for Prescription Digital Therapeutics (PDTs) that allows patients to connect and engage with physicians through its mobile application. The company was co-founded by the CEO Corey McCann, alongside Stephen Smith and William Greene. In 2020, Pear Therapeutics, Inc. In 2021, Pear Therapeutics, Inc. entered into a business combination agreement with Thimble Point Acquisition Corp. The transaction is valued at USD 125 million, at USD 10 per share. The company offers software-based disease treatment solutions that focus on specific areas such as reSET® – intended for substance use disorder, reSET-O® – for opioid use disorder, Somryst® – treatment for chronic insomnia, PEAR-004 – for schizophrenia, and PEAR-006 – for multiple sclerosis. Pear Therapeutics, Inc. also provides PearConnect, a patient service center used for Prescription Digital Therapeutics (or PDTs). The company generates revenue by selling software-based solutions to healthcare institutions. plans to use the investment to develop and commercialize the three commercial products under clinical trial. Post the closing of its business combination with Thimble, the company plans to list on the Nasdaq under the new ticker symbol, PEAR and will be renamed as Pear Holdings Corp.
Who invested in Pear Therapeutics
16 investors across 4 rounds
See all investors in Pear Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Pear Therapeutics
Who invested in Pear Therapeutics?
Pear Therapeutics has 16 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pear Therapeutics raised?
Pear Therapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Pear Therapeutics last raise money?
Pear Therapeutics's most recent round on record is a Series D, in Dec 2020.
What does Pear Therapeutics do?
Founded in 2013 and based in Massachusetts, US, Pear Therapeutics, Inc.
Where is Pear Therapeutics headquartered?
Pear Therapeutics is headquartered in Boston, US.
Which VCs invest in companies like Pear Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at Pear Therapeutics's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series D
Raising like Pear Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.